Views
Pipex Pharmaceuticals
From ArborWiki
Pipex Pharmaceuticals, Inc. ("Pipex") AMEX:PP is a development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and autoimmune diseases.
[edit] Stock information
Pipex is traded on the AMEX (ticker symbol PP).
[edit] In the news
- Pipex cuts jobs after drug application delay, Ann Arbor News, March 2008
- Ann Arbor's Pipex Pharmaceuticals Inc. cut 14 jobs and its president's salary in an attempt to quickly cut operating costs during a delay of the company's refiling of a new drug application for its lead drug candidate, oral tetrathiomolybdate or oral TTM.
- Pipex is developing late-stage drug candidates like oral TTM, formerly known as Coprexa, to treat neurological and autoimmune diseases like Wilson's disease. The initial application for oral TTM was rejected in January.
